Gut microbiota in the early stage of Crohn’s disease has unique characteristics

Abstract Background Emerging evidence suggests that gut microbiota plays a predominant role in Crohn’s disease (CD). However, the microbiome alterations in the early stage of CD patients still remain unclear. The present study aimed to identify dysbacteriosis in patients with early CD and explore sp...

Full description

Bibliographic Details
Main Authors: Xianzong Ma, Xiaojuan Lu, Wenyu Zhang, Lang Yang, Dezhi Wang, Junfeng Xu, Yan Jia, Xin Wang, Hui Xie, Shu Li, Mingjie Zhang, Yuqi He, Peng Jin, Jianqiu Sheng
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Gut Pathogens
Subjects:
Online Access:https://doi.org/10.1186/s13099-022-00521-0
_version_ 1798005035220598784
author Xianzong Ma
Xiaojuan Lu
Wenyu Zhang
Lang Yang
Dezhi Wang
Junfeng Xu
Yan Jia
Xin Wang
Hui Xie
Shu Li
Mingjie Zhang
Yuqi He
Peng Jin
Jianqiu Sheng
author_facet Xianzong Ma
Xiaojuan Lu
Wenyu Zhang
Lang Yang
Dezhi Wang
Junfeng Xu
Yan Jia
Xin Wang
Hui Xie
Shu Li
Mingjie Zhang
Yuqi He
Peng Jin
Jianqiu Sheng
author_sort Xianzong Ma
collection DOAJ
description Abstract Background Emerging evidence suggests that gut microbiota plays a predominant role in Crohn’s disease (CD). However, the microbiome alterations in the early stage of CD patients still remain unclear. The present study aimed to identify dysbacteriosis in patients with early CD and explore specific gut bacteria related to the progression of CD. Methods This study was nested within a longitudinal prospective Chinese CD cohort, and it included 18 early CD patients, 22 advanced CD patients and 30 healthy controls. The microbiota communities were investigated using high-throughput Illumina HiSeq sequencing targeting the V3–V4 region of 16S ribosomal DNA (rDNA) gene. The relationship between the gut microbiota and clinical characteristics of CD was analyzed. Results Differential microbiota compositions were observed in CD samples (including early and advanced CD samples) and healthy controls samples. Notably, Lachnospiracea_incertae_sedis and Parabacteroides were enriched in the early CD patients, Escherichia/Shigella, Enterococcus and Proteus were enriched in the advanced CD patients, and Roseburia, Gemmiger, Coprococcus, Ruminococcus 2, Butyricicoccus, Dorea, Fusicatenibacter, Anaerostipes, Clostridium IV were enriched in the healthy controls [LDA score (log10) > 2]. Furthermore, Kruskal–Wallis Rank sum test results showed that Blautia, Clostridium IV, Coprococcus, Dorea, Fusicatenibacter continued to significantly decrease in early and advanced CD patients, and Escherichia/Shigella and Proteus continued to significantly increase compared with healthy controls (P < 0.05). The PICRUSt analysis identified 16 remarkably different metabolic pathways [LDA score (log10) > 2]. Some genera were significantly correlated with various clinical parameters, such as fecal calprotectin, erythrocyte sedimentation rate, C-reactive protein, gland reduce, goblet cells decreased, clinical symptoms (P < 0.05). Conclusions Dysbacteriosis occurs in the early stage of CD and is associated with the progression of CD. This data provides a foundation that furthers the understanding of the role of gut microbiota in CD’s pathogenesis.
first_indexed 2024-04-11T12:33:58Z
format Article
id doaj.art-e86cf7179a474b0aaa8c5e72b4ec1662
institution Directory Open Access Journal
issn 1757-4749
language English
last_indexed 2024-04-11T12:33:58Z
publishDate 2022-12-01
publisher BMC
record_format Article
series Gut Pathogens
spelling doaj.art-e86cf7179a474b0aaa8c5e72b4ec16622022-12-22T04:23:41ZengBMCGut Pathogens1757-47492022-12-0114111310.1186/s13099-022-00521-0Gut microbiota in the early stage of Crohn’s disease has unique characteristicsXianzong Ma0Xiaojuan Lu1Wenyu Zhang2Lang Yang3Dezhi Wang4Junfeng Xu5Yan Jia6Xin Wang7Hui Xie8Shu Li9Mingjie Zhang10Yuqi He11Peng Jin12Jianqiu Sheng13Medical School of Chinese PLADepartment of Gastroenterology, The Seventh Medical Center of Chinese PLA General HospitalCapital Medical UniversityDepartment of Gastroenterology, The Seventh Medical Center of Chinese PLA General HospitalMedical School of Chinese PLASenior Department of Gastroenterology, The First Medical Center of Chinese PLA General HospitalDepartment of Gastroenterology, The Seventh Medical Center of Chinese PLA General HospitalDepartment of Gastroenterology, The Seventh Medical Center of Chinese PLA General HospitalDepartment of Gastroenterology, The Seventh Medical Center of Chinese PLA General HospitalDepartment of Gastroenterology, The Seventh Medical Center of Chinese PLA General HospitalDepartment of Gastroenterology, The Seventh Medical Center of Chinese PLA General HospitalDepartment of Gastroenterology, The Seventh Medical Center of Chinese PLA General HospitalDepartment of Gastroenterology, The Seventh Medical Center of Chinese PLA General HospitalMedical School of Chinese PLAAbstract Background Emerging evidence suggests that gut microbiota plays a predominant role in Crohn’s disease (CD). However, the microbiome alterations in the early stage of CD patients still remain unclear. The present study aimed to identify dysbacteriosis in patients with early CD and explore specific gut bacteria related to the progression of CD. Methods This study was nested within a longitudinal prospective Chinese CD cohort, and it included 18 early CD patients, 22 advanced CD patients and 30 healthy controls. The microbiota communities were investigated using high-throughput Illumina HiSeq sequencing targeting the V3–V4 region of 16S ribosomal DNA (rDNA) gene. The relationship between the gut microbiota and clinical characteristics of CD was analyzed. Results Differential microbiota compositions were observed in CD samples (including early and advanced CD samples) and healthy controls samples. Notably, Lachnospiracea_incertae_sedis and Parabacteroides were enriched in the early CD patients, Escherichia/Shigella, Enterococcus and Proteus were enriched in the advanced CD patients, and Roseburia, Gemmiger, Coprococcus, Ruminococcus 2, Butyricicoccus, Dorea, Fusicatenibacter, Anaerostipes, Clostridium IV were enriched in the healthy controls [LDA score (log10) > 2]. Furthermore, Kruskal–Wallis Rank sum test results showed that Blautia, Clostridium IV, Coprococcus, Dorea, Fusicatenibacter continued to significantly decrease in early and advanced CD patients, and Escherichia/Shigella and Proteus continued to significantly increase compared with healthy controls (P < 0.05). The PICRUSt analysis identified 16 remarkably different metabolic pathways [LDA score (log10) > 2]. Some genera were significantly correlated with various clinical parameters, such as fecal calprotectin, erythrocyte sedimentation rate, C-reactive protein, gland reduce, goblet cells decreased, clinical symptoms (P < 0.05). Conclusions Dysbacteriosis occurs in the early stage of CD and is associated with the progression of CD. This data provides a foundation that furthers the understanding of the role of gut microbiota in CD’s pathogenesis.https://doi.org/10.1186/s13099-022-00521-0Crohn’s diseaseEarly diagnosisGut microbiota16S rDNADysbacteriosis
spellingShingle Xianzong Ma
Xiaojuan Lu
Wenyu Zhang
Lang Yang
Dezhi Wang
Junfeng Xu
Yan Jia
Xin Wang
Hui Xie
Shu Li
Mingjie Zhang
Yuqi He
Peng Jin
Jianqiu Sheng
Gut microbiota in the early stage of Crohn’s disease has unique characteristics
Gut Pathogens
Crohn’s disease
Early diagnosis
Gut microbiota
16S rDNA
Dysbacteriosis
title Gut microbiota in the early stage of Crohn’s disease has unique characteristics
title_full Gut microbiota in the early stage of Crohn’s disease has unique characteristics
title_fullStr Gut microbiota in the early stage of Crohn’s disease has unique characteristics
title_full_unstemmed Gut microbiota in the early stage of Crohn’s disease has unique characteristics
title_short Gut microbiota in the early stage of Crohn’s disease has unique characteristics
title_sort gut microbiota in the early stage of crohn s disease has unique characteristics
topic Crohn’s disease
Early diagnosis
Gut microbiota
16S rDNA
Dysbacteriosis
url https://doi.org/10.1186/s13099-022-00521-0
work_keys_str_mv AT xianzongma gutmicrobiotaintheearlystageofcrohnsdiseasehasuniquecharacteristics
AT xiaojuanlu gutmicrobiotaintheearlystageofcrohnsdiseasehasuniquecharacteristics
AT wenyuzhang gutmicrobiotaintheearlystageofcrohnsdiseasehasuniquecharacteristics
AT langyang gutmicrobiotaintheearlystageofcrohnsdiseasehasuniquecharacteristics
AT dezhiwang gutmicrobiotaintheearlystageofcrohnsdiseasehasuniquecharacteristics
AT junfengxu gutmicrobiotaintheearlystageofcrohnsdiseasehasuniquecharacteristics
AT yanjia gutmicrobiotaintheearlystageofcrohnsdiseasehasuniquecharacteristics
AT xinwang gutmicrobiotaintheearlystageofcrohnsdiseasehasuniquecharacteristics
AT huixie gutmicrobiotaintheearlystageofcrohnsdiseasehasuniquecharacteristics
AT shuli gutmicrobiotaintheearlystageofcrohnsdiseasehasuniquecharacteristics
AT mingjiezhang gutmicrobiotaintheearlystageofcrohnsdiseasehasuniquecharacteristics
AT yuqihe gutmicrobiotaintheearlystageofcrohnsdiseasehasuniquecharacteristics
AT pengjin gutmicrobiotaintheearlystageofcrohnsdiseasehasuniquecharacteristics
AT jianqiusheng gutmicrobiotaintheearlystageofcrohnsdiseasehasuniquecharacteristics